Exiqon - Articles and news items

Industry Insight: An interview with Søren Morgenthaler Echwald

Issue 4 2008, Past issues / 2 August 2008 /

European Pharmaceutical Review speaks to Søren Morgenthaler Echwald, Vice President of Business Development at Exiqon regarding new developments in microRNA.

A new field in biomarker discovery and target identification

Issue 1 2007, Past issues / 25 January 2007 / Dr. Ina K. Dahlsveen, Exiqon

The last few years have seen a rush of discoveries within a new field of post-transcriptional gene regulation. microRNAs, or miRNAs for short, are small regulating RNAs akin to small interfering RNAs (siRNA), but which are naturally expressed in vivo. Originally discovered in C. elegans 14 years ago, these small 20-22 nucleotide non-coding RNA molecules bind specifically to target messenger RNAs (mRNA) blocking their translation into protein or causing their degradation.


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...